| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GreenLight Biosciences Holdings, PBC | Chief Scientific Officer | Stock Option (Right to Buy) | 319K | May 10, 2022 | Direct | ||
| Icosavax, Inc. | Former EVP, Head of Research and Development | Stock Option (Right to Buy) | 0 | Feb 19, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ICVX | Icosavax, Inc. | Feb 19, 2024 | 2 | $0 | 4 | Feb 20, 2024 | Former EVP, Head of Research and Development |
| ICVX | Icosavax, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 14, 2023 | EVP, Head of Research & Dev. |
| ICVX | Icosavax, Inc. | Jun 12, 2023 | 0 | $0 | 3 | Jun 14, 2023 | EVP, Head of Research & Dev. |
| GRNA | GreenLight Biosciences Holdings, PBC | May 10, 2022 | 1 | $0 | 4 | Aug 8, 2022 | Chief Scientific Officer |
| GRNA | GreenLight Biosciences Holdings, PBC | Feb 2, 2022 | 2 | $0 | 4 | Feb 4, 2022 | Chief Scientific Officer |
| GRNA | GreenLight Biosciences Holdings, PBC | Feb 2, 2022 | 0 | $0 | 3 | Feb 4, 2022 | Chief Scientific Officer |